INSTITUTE FOR PHYSICAL RESEARCH OF NATIONAL ACADEMY OF SCIENCES OF ARMENIA

Their core work

The Institute for Physical Research (IPR) is a national academy research centre in Ashtarak, Armenia that conducts experimental physics and advanced materials research. Their core work involves synthesizing and characterizing magnetic nanoparticles and nanostructured coatings, with a clear applied focus on using these materials in cancer therapy — specifically magnetic particle hyperthermia and targeted drug delivery. They also carry earlier expertise in radiation detection materials, having contributed to research on scintillating and Cerenkov fibres used in particle physics experiments. As an NAS-affiliated institute, they offer rigorous laboratory characterization capabilities and serve as a bridge for bringing South Caucasus scientific expertise into European research consortia.

What they specialise in

How they've shifted over time

In their first H2020 engagement (INTELUM, 2015–2019), IPR NAS RA contributed as a partner to research on radiation detection materials — scintillating and Cerenkov fibres used in particle physics instrumentation — reflecting a classical experimental physics tradition. By 2019, they had pivoted sharply toward nanomedicine: their coordinated project MaNaCa is entirely focused on magnetic nanohybrids for cancer therapy, with no thematic overlap with the earlier scintillator work. This is a significant directional shift — from fundamental detector physics toward applied biomedical nanotechnology — and they took on a leadership role in the new domain rather than remaining a junior partner.

IPR NAS RA is moving away from fundamental physics instrumentation toward applied nanomedicine, and their decision to coordinate MaNaCa suggests they are building the network and ambition to lead future health-oriented nanotechnology projects.

How they like to work

IPR NAS RA has experience in both roles: they joined INTELUM as a partner and then stepped up to coordinate MaNaCa, an MSCA-RISE staff exchange project spanning 19 partners across 12 countries. MSCA-RISE consortia are inherently large and internationally distributed, so working with IPR means engaging with a group accustomed to multi-partner mobility schemes rather than tight bilateral research partnerships. Their willingness to take on the coordinator role in MaNaCa suggests growing confidence in project management, but their track record is still limited to two projects.

Despite only two H2020 projects, IPR NAS RA has built connections with 19 unique consortium partners across 12 countries — a relatively broad footprint explained by their participation in MSCA-RISE, which by design involves large, geographically dispersed mobility networks. Their position in Armenia places them naturally in Widening Participation consortia seeking to include South Caucasus institutions.

What sets them apart

IPR NAS RA is one of very few H2020-experienced research institutions in the South Caucasus, making them a valuable entry point for consortia seeking to include Armenian or broader regional expertise under Widening Participation criteria. Their combination of classical physics instrumentation background and a newer focus on magnetic nanomaterials for cancer therapy is unusual — they bridge detector physics and nanomedicine rather than sitting squarely in either community. For consortium builders, they offer both the credibility of a National Academy institute and the practical benefit of geographic diversity in a region rarely represented in EU projects.

Highlights from their portfolio

• MaNaCa
  IPR NAS RA coordinated this MSCA-RISE project on magnetic nanohybrids for cancer therapy — their only funded project as lead and the source of all their current keyword expertise.
• INTELUM
  Their debut H2020 engagement, contributing physics expertise to an international scintillating fibre research consortium — showing a different technical tradition from their current nanomedicine focus.